Table 1 Infectious disease emergency events and the military-civilian cooperative response
Infectious disease events | Year | Military-civilian contributions |
|---|---|---|
SARS | 2003 | First isolation of the virus; sequencing of the entire virus genome; development of rapid diagnosis assays; establishment of SARS-designated hospitals and treatment of the patients |
H5N1 avian flu | 2004 to 2005 | Large-scale industrial development of the Tamiflu equivalent, Oseltamivir (brand name KeWei) |
H1N1 flu | 2009 | Confirmation of first input H1N1 infected case; development of rapid diagnosis assays and RT-PCR; development of Peramivir Trihydrate and H1N1 flu vaccine |
H7N9 flu | 2013 to 2016 | Development of rapid diagnosis assays and RT-PCR; development of Peramivir and sodium chloride injection |
Ebola hemorrhagic fever | 2014 to 2015 | Deployment of testing teams and mobile hospitals; treatment of patients and training of the health care workers; establishment and operation of biosafety III laboratory; development of Ebola drug MIL 77 and vaccine |
Zika virus infection | 2015 to 2016 | Confirmation of first input Zika virus infection case; isolation of Zika virus strains; gene sequencing of the first imported Zika virus; development of rapid diagnosis assays |